Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nikitas

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
JCO Precision Oncology|November 10, 2022
Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma With CNS Metastasis: A Case ReportAntonia Angeli Gazola, Deborah Wong, Robert Chin, et al.
World Journal of Urology|March 16, 2024
Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancerJohn Nikitas, Amar Kishan, Albert Chang, et al.
Clinical Advances in Hematology & Oncology : H&O|August 30, 2023
Selecting the optimal radiation modality in prostate cancerLuca F Valle, Amar U Kishan, Antonio Franco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate CancerJohn Nikitas, Angela Castellanos Rieger, Andrea Farolfi, et al.
European Urology|March 17, 2024
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical TrialJohn Nikitas, Matthew Rettig, John Shen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
Scientific Reports|October 17, 2024
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapyJohn Nikitas, Andrei Gafita, Matthias R Benz, et al.
JTO Clinical and Research Reports|July 30, 2024
Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung CancerJohn Nikitas, Jane Yanagawa, Sandra Sacks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)John Nikitas, Ethan Lam, Kiara Adame Booker, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|November 10, 2022
Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma With CNS Metastasis: A Case ReportAntonia Angeli Gazola, Deborah Wong, Robert Chin, et al.
World Journal of Urology|March 16, 2024
Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancerJohn Nikitas, Amar Kishan, Albert Chang, et al.
Clinical Advances in Hematology & Oncology : H&O|August 30, 2023
Selecting the optimal radiation modality in prostate cancerLuca F Valle, Amar U Kishan, Antonio Franco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate CancerJohn Nikitas, Angela Castellanos Rieger, Andrea Farolfi, et al.
European Urology|March 17, 2024
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical TrialJohn Nikitas, Matthew Rettig, John Shen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
Scientific Reports|October 17, 2024
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapyJohn Nikitas, Andrei Gafita, Matthias R Benz, et al.
JTO Clinical and Research Reports|July 30, 2024
Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung CancerJohn Nikitas, Jane Yanagawa, Sandra Sacks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)John Nikitas, Ethan Lam, Kiara Adame Booker, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Pageof 4